Results 231 to 240 of about 170,276 (307)

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

British Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang, Chen‐Han Chueh, Chien‐Yu Tseng, Christopher N. Kaufmann, Earl J. Morris, Chiao‐En Wu, Yi‐Wen Tsai   +6 more
wiley   +1 more source

Effect of intravenous immunoglobulin combined with azithromycin sequential therapy on clinical outcomes and immune response in children with <i>Mycoplasma pneumoniae</i> pneumonia: a retrospective study. [PDF]

Front Med (Lausanne)
Guo H.
europepmc   +1 more source

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Spatio-temporal patterns and vaccination effectiveness in rabies risk using surveillance data from Kaduna State, Nigeria. [PDF]

BMC Public Health
Haruna EG, Madaki PD, Udechukwu CC, Tauna KH, Jolayemi KO.   +4 more
europepmc   +1 more source

Active surveillance of drug safety in healthcare data: Sequential monitoring of bacterial and serious urinary tract infection risk in sodium‐glucose cotransporter 2 inhibitor users

British Journal of Clinical Pharmacology, EarlyView.
Abstract Introduction Active surveillance of adverse events using healthcare data is emerging as complementary to the monitoring of spontaneous reports and stand‐alone pharmacoepidemiologic studies. The risk of urinary tract infections (UTIs) was listed as a special warning for sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) when marketed in Europe
Haoxin Le, Dilsad Simay Peker, Lukas Frederic Westphal, Nikolai Brun, Christine Erikstrup Hallgreen, Morten Andersen   +5 more
wiley   +1 more source

The Association Between Diabetes Mellitus During Pregnancy and Retinopathy of Prematurity. [PDF]

J Clin Med
Saaida L, Shany E, Imtirat A, Burrack N, Novack V, Eshkoli T.   +5 more
europepmc   +1 more source

Occupational skin health risk among nurses: development and validation of a nomogram-based prediction model. [PDF]

Front Public Health
Xu Y, Lu T, Feng L, Chen Y, Chen S, Xiong R.   +5 more
europepmc   +1 more source

Epidemiological investigation and risk factors of Peste des Petits Ruminants (PPR) in goats of Northeastern Bangladesh. [PDF]

Vet Anim Sci
Kahir MA, Mamun TI, Saeed MA, Islam MK, Ahsan MI, Akter S, Paul S, Uddin MB, Ahmed SSU.   +8 more
europepmc   +1 more source

Aligning statistical models with inference goals in the neuroscience of language: A dual-dependency taxonomy. [PDF]

Imaging Neurosci (Camb)
Bouton S, Chambon V, Golestani N, Formisano E, Proix T, Giraud AL.   +5 more
europepmc   +1 more source